Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Avon wins $26m Nato respirator, filter order

(Sharecast News) - Avon Technologies said it had won a $20.6m European order for respirators and filters through Nato's Support and Procurement Agency. The order will be delivered over fiscal 2026 and 2027, the company said on Thursday. The FM50 respirator and FM61EU filter, is designed to protect the wearer from chemical, biological, radiological and nuclear threats.

Avon's protection division was awarded the 10-year NSPA FM50 contract in 2020, enabling Nato nations and partners to purchase the respirator, filters and related accessories.

"This order further underpins the Group's expectations for FY2026 and beyond, in line with the guidance provided at the full year results in November 2025," Avon added in a statement.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Funding Circle signs new £700m forward flow deal with Waterfall
(Sharecast News) - SME finance platform Funding Circle has announced a £700m deal with Waterfall Asset Management to provide funding for its shorter-term loan product.
Nuveen's price for Schroders 'too cheap', says Panmure Liberum
(Sharecast News) - Panmure Liberum said on Thursday that US investment manager Nuveen's 612p a share takeover offer for Schroders is "too cheap" and "only a touch ahead of where we might have been pitching a new target price in an independent world".
Magnum Ice Cream results fail to impress as operating profit slides
(Sharecast News) - Shares in Magnum Ice Cream tumbled on Thursday as its first full-year results since the recent demerger from Unilever failed to impress.
THG strikes deal with Greencore to sell protein-enriched convenience foods
(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.